PURPOSE: We investigated the roles of age, vitamin B(12) markers, and the 5,10-methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism as determinants of folate forms in serum. METHODS: We measured the serum concentrations of (6S)-5-CH(3)-H(4)folate, (6S)-H(4)folate, (6S)-5-HCO-H(4)folate, (6R)-5,10-CH(+)-H(4)folate, and folic acid in 146 non-supplemented older participants (median age 74 years). The concentrations of total vitamin B(12), holotranscobalamin (holoTC), methylmalonic acid (MMA), and total homocysteine (tHcy) were also measured. RESULTS: Elevated metabolites (MMA > 271 nmol/L and tHcy > 12.0 μmol/L) were found in 24.0 and 63.0 % of the participants, respectively. We found a significant age-dependent decrease (participants with a median age of 87 years compared with participants with a median age of 60 years) in the sum of serum folate levels, the (6S)-5-CH(3)-H(4)folate concentration, and the (6S)-5-CH(3)-H(4)folate proportion. In addition, participants with elevated metabolite levels were older, had lower concentrations of the sum of folates and (6S)-5-CH(3)-H(4)folate, and had higher concentrations of (6S)-5-CHO-H(4)folate and creatinine but had a comparable holoTC/total vitamin B(12) ratio. No association was found between the MTHFR C677T genotype and serum folate forms. CONCLUSION: Low serum (6S)-5-CH(3)-H(4)folate concentrations and the proportion of (6S)-5-CH(3)-H(4)folate (percentage of the sum of folate forms) are related to older age and elevated MMA and tHcy levels.
PURPOSE: We investigated the roles of age, vitamin B(12) markers, and the 5,10-methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism as determinants of folate forms in serum. METHODS: We measured the serum concentrations of (6S)-5-CH(3)-H(4)folate, (6S)-H(4)folate, (6S)-5-HCO-H(4)folate, (6R)-5,10-CH(+)-H(4)folate, and folic acid in 146 non-supplemented older participants (median age 74 years). The concentrations of total vitamin B(12), holotranscobalamin (holoTC), methylmalonic acid (MMA), and total homocysteine (tHcy) were also measured. RESULTS: Elevated metabolites (MMA > 271 nmol/L and tHcy > 12.0 μmol/L) were found in 24.0 and 63.0 % of the participants, respectively. We found a significant age-dependent decrease (participants with a median age of 87 years compared with participants with a median age of 60 years) in the sum of serum folate levels, the (6S)-5-CH(3)-H(4)folate concentration, and the (6S)-5-CH(3)-H(4)folate proportion. In addition, participants with elevated metabolite levels were older, had lower concentrations of the sum of folates and (6S)-5-CH(3)-H(4)folate, and had higher concentrations of (6S)-5-CHO-H(4)folate and creatinine but had a comparable holoTC/total vitamin B(12) ratio. No association was found between the MTHFRC677T genotype and serum folate forms. CONCLUSION: Low serum (6S)-5-CH(3)-H(4)folate concentrations and the proportion of (6S)-5-CH(3)-H(4)folate (percentage of the sum of folate forms) are related to older age and elevated MMA and tHcy levels.
Authors: Regan L Bailey; James L Mills; Elizabeth A Yetley; Jaime J Gahche; Christine M Pfeiffer; Johanna T Dwyer; Kevin W Dodd; Christopher T Sempos; Joseph M Betz; Mary Frances Picciano Journal: Am J Clin Nutr Date: 2010-06-23 Impact factor: 7.045
Authors: Linda F Fried; Michael G Shlipak; Casey Crump; Anthony J Bleyer; John S Gottdiener; Richard A Kronmal; Lewis H Kuller; Anne B Newman Journal: J Am Coll Cardiol Date: 2003-04-16 Impact factor: 24.094
Authors: Robert Clarke; J Grimley Evans; J Schneede; E Nexo; C Bates; A Fletcher; A Prentice; C Johnston; P M Ueland; H Refsum; P Sherliker; J Birks; G Whitlock; E Breeze; J M Scott Journal: Age Ageing Date: 2004-01 Impact factor: 10.668
Authors: Lars Orning; Anne Rian; Andrew Campbell; Jeff Brady; Sergey N Fedosov; Birgit Bramlage; Keith Thompson; Edward V Quadros Journal: Nutr Metab (Lond) Date: 2006-01-04 Impact factor: 4.169
Authors: Rima Obeid; Susanne H Kirsch; Sarah Dilmann; Cosima Klein; Rudolf Eckert; Jürgen Geisel; Wolfgang Herrmann Journal: Eur J Nutr Date: 2015-05-06 Impact factor: 5.614
Authors: Yvonne Wettergren; Helena Taflin; Elisabeth Odin; Karl Kodeda; Kristoffer Derwinger Journal: Cancer Chemother Pharmacol Date: 2014-10-24 Impact factor: 3.333